The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ackermann, L. W.
Right arrow Articles by Denning, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ackermann, L. W.
Right arrow Articles by Denning, G. M.
The Journal of Immunology, 1999, 162: 5112-5118.
Copyright © 1999 by The American Association of Immunologists

IL-4 and IFN-{gamma} Increase Steady State Levels of Polymeric Ig Receptor mRNA in Human Airway and Intestinal Epithelial Cells1

Laynez W. Ackermann, Laura A. Wollenweber and Gerene M. Denning2

Infectious Diseases Research Laboratory, Veterans Affairs Medical Center, and Department of Internal Medicine, University of Iowa, Iowa City, IA 52242

Delivery of IgA to the mucosal surface occurs via transcytosis of polymeric IgA (pIgA) across the epithelium, a process mediated by the pIgR. Several factors increase pIgR expression in human epithelial cells, including IL-4 and IFN-{gamma}. Using an RNase protection assay, we found that IL-4 and IFN-{gamma} increase steady state levels of pIgR mRNA in both human intestinal (HT29) and airway (Calu-3) epithelial cells. Time course studies in HT29 clone 19A cells showed that with each cytokine alone and with both together: 1) there was a significant lag before mRNA levels increased; 2) maximal levels were not reached until 48–72 h after the addition of cytokines; 3) mRNA levels remained elevated in the continued presence of cytokines; and 4) addition of actinomycin D or removal of cytokines led to decreases in mRNA levels with a half-life of ~20–28 h. Cytokine-dependent increases in steady state levels of pIgR mRNA were inhibited by cycloheximide and by protein tyrosine kinase inhibitors but not by inhibitors of protein kinase C or cAMP-dependent protein kinase A. Both IFN-{gamma} and IL-4 increased expression of the inducible transcription factor IFN regulatory factor-1 (IRF-1), but levels of IRF-1 only weakly correlated with levels of pIgR mRNA, suggesting that additional transcription factors are required. These studies provide additional insights into the mechanisms by which cytokines regulate expression of the pIgR, a central player in mucosal immunity.




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
K. Pal, C. S. Kaetzel, K. Brundage, C. A. Cunningham, and C. F. Cuff
Regulation of polymeric immunoglobulin receptor expression by reovirus
J. Gen. Virol., August 1, 2005; 86(8): 2347 - 2357.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
O. Lesur, M. Brisebois, A. Thibodeau, F. Chagnon, D. Lane, and T. Fullop
Role of IFN-{gamma} and IL-2 in rat lung epithelial cell migration and apoptosis after oxidant injury
Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L4 - L14.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Schjerven, P. Brandtzaeg, and F.-E. Johansen
Hepatocyte NF-1 and STAT6 Cooperate with Additional DNA-Binding Factors to Activate Transcription of the Human Polymeric Ig Receptor Gene in Response to IL-4
J. Immunol., June 15, 2003; 170(12): 6048 - 6056.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. P. Simmons, N. S. Goncalves, M. Ghaem-Maghami, M. Bajaj-Elliott, S. Clare, B. Neves, G. Frankel, G. Dougan, and T. T. MacDonald
Impaired Resistance and Enhanced Pathology During Infection with a Noninvasive, Attaching-Effacing Enteric Bacterial Pathogen, Citrobacter rodentium, in Mice Lacking IL-12 or IFN-{gamma}
J. Immunol., February 15, 2002; 168(4): 1804 - 1812.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. J. V. Galietta, P. Pagesy, C. Folli, E. Caci, L. Romio, B. Costes, E. Nicolis, G. Cabrini, M. Goossens, R. Ravazzolo, et al.
IL-4 Is a Potent Modulator of Ion Transport in the Human Bronchial Epithelium In Vitro
J. Immunol., January 15, 2002; 168(2): 839 - 845.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. Pilette, Y. Ouadrhiri, V. Godding, J-P. Vaerman, and Y. Sibille
Lung mucosal immunity: immunoglobulin-A revisited
Eur. Respir. J., September 1, 2001; 18(3): 571 - 588.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Schjerven, P. Brandtzaeg, and F.-E. Johansen
Mechanism of IL-4-Mediated Up-Regulation of the Polymeric Ig Receptor: Role of STAT6 in Cell Type-Specific Delayed Transcriptional Response
J. Immunol., October 1, 2000; 165(7): 3898 - 3906.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.